Shikonin ameliorates Experimental Autoimmune Encephalomyelitis (EAE) via Immuno-modulatory, anti-apototic, and anti-oxidative activity
Preprint
- 21 May 2020
- preprint
- Published by Springer Nature in Research Square
Abstract
Background Multiple sclerosis is a common auto-immuno-inflammatory diseases of the central nervous system in adults. There are several underlying mechanisms for pathogenesis of the disease, including inflammation, oligodendrocyte apoptosis, and oxidative stress. Methods We have investigated the mechanism of Shikonin action in C57BL/6 experimental autoimmune encephalomyelitis (EAE) model of multiple sclerosis. Results Our results revealed that EAE induction significantly increased the extent of demyelination in the corpus callosum tissues of the animals, while treatment of the mice with Shikonin, significantly decreased the extent of demyelination. Real-time PCR based analyzing the brain samples from the EAE mice, revealed a significant enhancement in the expression level of TNF-α , IFN-γ and Bax genes as well as a reduction in the expression level of TGF-β and Bcl2. Shikonin treatment significantly reduced the expression level of TNF-α , IFN-γ and Bax. On the other hand, the expression levels of TGF-β and Bcl2 as well as the Glutathione peroxidase-1 (GPX-1) enzyme were significantly increased following Shikonin treatment. Conclusion This study emphasizes the immune-modulatory, anti-apoptotic, and anti-oxitive effects of Shikonin, which may have an important healing influence on the severity of EAE.Keywords
All Related Versions
This publication has 27 references indexed in Scilit:
- Curcumin ameliorates experimental autoimmune encephalomyelitis in a C57BL/6 mouse modelDrug Development Research, 2019
- Thymosins in multiple sclerosis and its experimental models: moving from basic to clinical applicationMultiple Sclerosis and Related Disorders, 2019
- Polymerized nano-curcumin attenuates neurological symptoms in EAE model of multiple sclerosis through down regulation of inflammatory and oxidative processes and enhancing neuroprotection and myelin repairNeuropharmacology, 2015
- Shikonin Protects Dopaminergic Cell Line PC12 Against 6-Hydroxydopamine-Mediated Neurotoxicity Via Both Glutathione-Dependent and Independent Pathways and by Inhibiting ApoptosisNeurochemical Research, 2013
- Distinct pathological patterns in relapsing–remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetateJournal of Autoimmunity, 2011
- Shikonin protects mouse brain against cerebral ischemia/reperfusion injury through its antioxidant activityEuropean Journal of Pharmacology, 2010
- Oxidative stress in serum and peripheral blood leukocytes in patients with different disease courses of multiple sclerosisJournal of Neurology, 2005
- Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosisEuropean Journal of Immunology, 2005
- Virtues and pitfalls of EAE for the development of therapies for multiple sclerosisTrends in Immunology, 2005
- Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitisJournal of Molecular Medicine, 1997